CD300A and focal segmental glomerulosclerosis: Using a public dataset (Nephroseq v5, http://v5.nephroseq.org) of gene expression profiles in CKD patients, CD300A expression was significantly higher in patients with CKD due to diabetic nephropathy and focal segmental glomerulosclerosis than in control patients (Figure 7A).